Johnson & Johnson (JNJ) Approaches Actelion About a Takeover
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Johnson & Johnson (JNJ) Confirms Talks with Actelion on Possible Takeover
November 25, 2016 11:58 AM ESTJohnson & Johnson (NYSE: JNJ) today confirmed it is engaged in preliminary discussions with Actelion Pharmaceuticals Ltd. (SIX: ATLN) (OTC: ALIOY) regarding a potential transaction.
There can be no... MoreActelion Confirms Johnson & Johnson (JNJ) Takeover Approach
November 25, 2016 11:00 AM ESTActelion (OTC: ALIOY) confirmed it has been approached by Johnson & Johnson (NYSE: JNJ) about a possible transaction.
The company said there can be no certainty that a transaction will result.
StreetInsider first... More
Actelion (ALIOY) Said to Attract Takeover Interest - Source
November 23, 2016 3:15 PM ESTSwitzerland-based Actelion has attracted takeover interest, according to a person claiming to have knowledge of the matter. The source hinted that the mystery buyer is likely a major U.S.-based pharmaceutical company, but he wouldn't reveal the bidders name or the offer price. The ADR's of Actelion trade... More